DBOT - Demegen, Inc. (fka DBOT)

[jmhollen]

Recent News:

11/5/02 Demegen Receives Orphan Drug Designation for P113D for Treatment of Cystic Fibrosis
9/12/02 Shareholder Meeting Remarks by Richard D. Ekstrom
8/27/02 Demegen Awarded European Patents for D-Amino Acid Peptides
1/29/02 Demegen Announces Organizational Changes -- Reduces Operating Costs and Will Focus on Co-Development and Licensing -- Company Has Four Excellent Drug Candidates in Pipeline
1/8/02 Demegen Scientists Publish Antibacterial Activity of P113D against Cystic Fibrosis Infections
10/24/01 Demegen Receives Another Research Grant from the CFF to Expand Pipeline for the Treatment of Cystic Fibrosis Pulmonary Infections
8/22/01 Demegen Receives $1.5 Million Grant to Develop a Treatment for Cystic Fibrosis Infections

.